NeoImmuneTech (XKRX:950220) Total Tax Payable : ₩58.51 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Total Tax Payable?

NeoImmuneTech's Total Tax Payable for the quarter that ended in Dec. 2023 was ₩58.51 Mil.

NeoImmuneTech's quarterly Total Tax Payable increased from Jun. 2023 (₩122.19 Mil) to Sep. 2023 (₩147.48 Mil) but then declined from Sep. 2023 (₩147.48 Mil) to Dec. 2023 (₩58.51 Mil).

NeoImmuneTech's annual Total Tax Payable increased from Dec. 2021 (₩59.33 Mil) to Dec. 2022 (₩92.49 Mil) but then declined from Dec. 2022 (₩92.49 Mil) to Dec. 2023 (₩58.51 Mil).

NeoImmuneTech Total Tax Payable Historical Data

The historical data trend for NeoImmuneTech's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Total Tax Payable Chart

NeoImmuneTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

21.63

59.33

92.49

58.51

NeoImmuneTech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Tax Payable	Get a 7-Day Free Trial											92.49	-	122.19	147.48	58.51

NeoImmuneTech Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

NeoImmuneTech Total Tax Payable Related Terms

Thank you for viewing the detailed overview of NeoImmuneTech's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoImmuneTech (XKRX:950220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850

Website

http://www.neoimmunetech.com

NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines